Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Hisse Senetlerindeki Sıralama #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Hisse Fiyatı
$0.117
Son senkronizasyon: 2025-04-04
Piyasa Değeri
$2.45M
Değişim (1 gün)
-13.59%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Carmell Therapeutics Corporation (CTCX)

Kategori

Carmell Therapeutics Corporation (CTCX) için EPS
June 2026 itibariyle EPS TTM: $-4.71
Carmell Therapeutics Corporation şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $-4.71'dir. 2023 yılı sonunda, şirketin EPS'si $-0.74 idi; bu, 2022 yılındaki EPS olan $-0.50 ile önceki yıla göre artış.
Carmell Therapeutics Corporation için 2021 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
Benzer şirketler veya rakipler için EPS
Şirket EPS EPS Farkı Ülke
$17.32 -467.73%
US
$27.74 -688.96%
NL
- -
CH
- -
KR
$13.70 -390.87%
BE